Navigation Links
Unique Bone Marrow Transplant Said to Cure Sickle Cell
Date:11/14/2008

Technique is safe and effective, say Children's Hospital of Pittsburgh reseachers

FRIDAY, Nov. 14 (HealthDay News) -- A unique form of bone marrow transplantation is the only safe and effective cure for sickle cell disease, researchers at Children's Hospital of Pittsburgh report.

Traditional bone marrow transplants rely on heavy doses of chemotherapy prior to transplant in order to destroy a recipient's bone marrow so it won't reject the donated marrow. But that makes patients vulnerable to dangerous complications, something that's viewed as an unnecessary risk, because sickle cell disease typically isn't life-threatening, the researchers said.

This new transplant method relies on reduced intensity conditioning (RIC) regimens, which are less toxic to patients and eliminate life-threatening side effects generally associated with bone marrow transplantation. This means transplants can be offered to patients with severe sickle cell disease.

The researchers at Children's Hospital, part of the University of Pittsburgh Medical Center, reported that six of seven sickle cell patients who received RIC bone marrow transplants in the last decade now have donor marrow and are free of sickle cell disease symptoms.

The report was published in the November issue of the journal Biology of Blood and Marrow Transplantation.

"Bone marrow transplant is the only known cure for sickle cell disease. But doctors have avoided performing them in these patients, because complications from a traditional bone marrow transplant can be life-threatening," Dr. Lakshmanan Krishnamurti, a pediatric hematologist/oncologist and director of the Sickle Cell Program at Children's Hospital, said in a hospital news release. He helped develop RIC bone marrow transplants.

"Through the reduced-intensity approach we developed, the potential for complications is dramatically lessened. This study offers hope for a cure for t
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Unique Holiday Gift for Animal Lovers: A Donation to Fund Animal Health Research; Pick a Favorite Animal - Dog, Cat, Horse, All Species of Wildlife
2. Former NBA and Boston Celtic Star Dee Brown Joins PrimeTime Sports, Boca Ratons Unique Sports Training Facility
3. New Stop Smoking Aid Offers Unique Teeth Whitening Benefit
4. Wolters Kluwer Healths Unique Prescription Data Tapped by FDA in Effort to Advance Drug Safety
5. The Maurer Foundation Promotes Breast Health Message With Unique Traveling Pink Bus
6. All-New Doctor.com Unites Powerful Doctor Search with Unique Social Media Features
7. Unique Way to Help Your Favorite Animal - Morris Animal Foundations 2009 Sponsorship Guide Provides Nearly 200 Options
8. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
9. 2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event
10. NIH launches unique effort to advance study of urologic chronic pelvic pain disorders
11. Arteries from distinct regions of the body have unique immune functions

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Unique Bone Marrow Transplant Said to Cure Sickle Cell
Unique Bone Marrow Transplant Said to Cure Sickle Cell
(Date:11/27/2009)...,, KIBBUTZSHAMIR,Israel,Nov.27/PRNewswire-First...Shamir" ),aleadingproviderofinnovativeproductsandt...hatitsboardofdirectorshaddeclaredadividenddistribu...yNIS37.62millionbasedontheNovember25,2009represent...ximatelyNIS2.3basedontheNovember25,2009representat...
(Date:11/27/2009)... Voyant Health™ annou...higan) has licensed its TraumaCad Enterprise ortho... workflow solution. , (PR...ounced today that Spectrum Health (Grand Rapids, M...hopedic templating solution and its TraumaCad Exte...
(Date:11/26/2009)...,, PRINCETON,N.J.,Nov.27/PRNewswire/--Thediabet...henext25yearsandannualmedicalspendingonthediseasei...accordingtoastudypublishedintheDecemberissueof Dia...ram(NCDP),aprogramofNovoNordisk,commissionedtheana...rdingtotheforecast,thenumberofAmericanslivingwithd...
(Date:11/26/2009)... No more letters from the N...personalized text messages from Santa , ...ort to increase operational efficiencies at the No...to help keep children all over the globe informed ...lves in Santa’s research department have ide...
(Date:11/25/2009)...,, EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--W...tist.Butachiropractorcanalsogivepatientsthehelpthe...hiswhereyourjaw(mandible)contacts/connectswithyour...sociatedwithTMJdysfunctionarepainwithchewing,click...edfromTMJdysfunctionincluding:headaches,fatigue,sl...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...women demand epidurals during delivery even if not...atest demand of midwives through the experts at Ro... would help stem the// growing number of women ask...pidural though relieves pain during child birth, t...
...cer has acquired a new twist in its sordid journey...d upon “Stem Cells” and their involvement in the d...ation to say that stem cells may hold clues for la...his is probably the reason why a tumor resurfaces ...
... Vado Diomande, a childhood dancer, from the tende...“Mask Dance” has suffered a setback to his health....ts, as it was thought to be. // On Thursday,...etching the animal skins on drums for the purpose ...
...en are too busy building careers, and raking in th...babies that result in delayed motherhood, reveals ...very boring read, a loss of 92,000 babies each yea... of infertility. But Women seem to be stuck up on ...
...ew study appearing in the February 22 issue of the... no significant differences in the effectiveness o... or paclitaxel. Drug-releasing stents are known to...r the outcome of procedures like angioplasty, when...
...thwestern Memorial Hospital along with Northwester...ting a Phase II clinical trial to determine if ava...drug also known as bevacizumab is an anti-angiogen...adiation therapy and chemotherapy can reduce local...
Other Medicine News:Health News:Avastin under trial to test efficacy for pancreatic tumours! 2
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--...f advanceddiagnosticandspecialtyproductstothevete...agnosticsCorporationforthesupplyofbloodgasproducts..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...passionforinnovatinginthefieldofadvancedpoint-of-c...
(Date:11/25/2009)..., PRINCETON,N.J.,Nov.25/PRNewswire-FirstCall/--...aceuticalcompanycommittedtodiscovering,developinga...reportedfinancialresultsforthefiscalyearendedSepte...illionincash,cashequivalentsandshortterminvestment...RG7128 ,, Phase2bTrial ,, InlateNovembe...
(Date:11/25/2009)..., CHICAGOandSTAFA,Switzerland,Nov.25/PRNewswire...rofinnovativehearingsolutions,presentedtheseconded...nthespecialneedsoftheolderpopulation.Theconference...omaroundtheworldandmorethan250clinicianswhoworkeve...ytoshareexperiencesanddiscussthelatestresearchandt...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3FDA Acts to Protect Public Health from Electronic Cigarettes 52470 1FDA Acts to Protect Public Health from Electronic Cigarettes 52470 2FDA Acts to Protect Public Health from Electronic Cigarettes 52470 3Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 1Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 2Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 1Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 4Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 5Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 6Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 7Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 8
...rship Strengthened with Clinical Trials S...PANY, N.J. and ATLANTA, Sept. 6 Image Solutions,I...quire Zurich,Biostatistics, Inc. (ZBI). With the L...gulatory submissions, the acquisition further stre...Consortium (CDISC) capabilities,the FDA-supported ...
...tor to Enter Registration Trials, HAYWARD, Calif.... KOSN ) today announced that it has successfully,... Drug Administration,(FDA) on the design of its TI...s Hsp90 inhibitor tanespimycin as a treatment for ...Special Protocol Assessment (SPA),process, Kosan a...
Other Medicine Technology:Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 2Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
...chairs with concave seats and large backrests with...backrests, armrests, and casters and glides. &bull...riety of environments including: industry, educati... care and office. • With reinforced nylon bas...
BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q72-CAB-ERB
BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q70-CAB-ERB
...chairs with concave seats and large backrests with...backrests, armrests, and casters and glides. &bull...riety of environments including: industry, educati... care and office. • With cast aluminum base &...
Medicine Products: